comparemela.com

Latest Breaking News On - International vascular biology - Page 1 : comparemela.com

Inozyme Pharma Reports Third Quarter 2022 Financial Results and Provides Business Updates

10.11.2022 - - Topline data from Phase 1/2 clinical trial of INZ-701 in ENPP1 Deficiency on track for the fourth quarter of 2022 – - Topline data from Phase 1/2 clinical trial of INZ-701 in ABCC6 Deficiency on track for the first quarter of 2023 – .

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.